CompuGroup Medical Societas Europaea revenue reports
CompuGroup Medical Societas Europaea financial reports, CompuGroup Medical Societas Europaea annual revenue in 2024. When does CompuGroup Medical Societas Europaea report revenue?
CompuGroup Medical Societas Europaea total revenue, net income and dynamics of changes in Euro today
The dynamics of net revenue of CompuGroup Medical Societas Europaea rose. The change amounted to 12 077 000 €. The dynamics of net revenue is shown in comparison with the previous report. CompuGroup Medical Societas Europaea net income is now 17 163 000 €. The dynamics of CompuGroup Medical Societas Europaea net income rose by 6 188 000 €. The assessment of the dynamics of CompuGroup Medical Societas Europaea net income was made in comparison with the previous report. The financial schedule of CompuGroup Medical Societas Europaea consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The financial report chart shows the values from 31/03/2019 to 30/06/2021. The value of all CompuGroup Medical Societas Europaea assets on the graph is shown in green.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
248 891 000 €
+29.91 % ↑
17 163 000 €
+22.83 % ↑
31/03/2021
236 814 000 €
+31.32 % ↑
10 975 000 €
-46.198 % ↓
31/12/2020
249 889 000 €
+16.92 % ↑
9 403 000 €
-55.749 % ↓
30/09/2020
238 974 000 €
+29.35 % ↑
34 776 000 €
+92.55 % ↑
31/12/2019
213 725 000 €
-
21 249 000 €
-
30/09/2019
184 743 000 €
-
18 061 000 €
-
30/06/2019
191 592 000 €
-
13 973 000 €
-
31/03/2019
180 333 000 €
-
20 399 000 €
-
Show:
to
CompuGroup Medical Societas Europaea financial report charts
Dates of CompuGroup Medical Societas Europaea finance reports: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of CompuGroup Medical Societas Europaea is available online for such a date - 30/06/2021. Gross profit CompuGroup Medical Societas Europaea is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit CompuGroup Medical Societas Europaea is 83 594 000 €
CompuGroup Medical Societas Europaea quarterly report dates
Cost of revenue CompuGroup Medical Societas Europaea is the total cost of producing and distributing of products and services of a company. Cost of revenue CompuGroup Medical Societas Europaea is 165 297 000 € Total revenue CompuGroup Medical Societas Europaea refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue CompuGroup Medical Societas Europaea is 248 891 000 € Operating income CompuGroup Medical Societas Europaea is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income CompuGroup Medical Societas Europaea is 26 886 000 €
Net income CompuGroup Medical Societas Europaea is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income CompuGroup Medical Societas Europaea is 17 163 000 € Current assets CompuGroup Medical Societas Europaea is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets CompuGroup Medical Societas Europaea is 333 106 000 € Total assets CompuGroup Medical Societas Europaea refers to the total amount of assets owned by a person or entity. Total assets CompuGroup Medical Societas Europaea is 1 683 947 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
83 594 000 €
80 881 000 €
95 178 000 €
102 140 000 €
81 884 000 €
70 710 000 €
64 893 000 €
66 861 000 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
165 297 000 €
155 933 000 €
154 711 000 €
136 834 000 €
131 841 000 €
114 033 000 €
126 699 000 €
113 472 000 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
248 891 000 €
236 814 000 €
249 889 000 €
238 974 000 €
213 725 000 €
184 743 000 €
191 592 000 €
180 333 000 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
213 725 000 €
184 743 000 €
191 592 000 €
180 333 000 €
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
26 886 000 €
17 549 000 €
19 369 000 €
47 982 000 €
35 374 000 €
22 095 000 €
23 256 000 €
31 336 000 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
17 163 000 €
10 975 000 €
9 403 000 €
34 776 000 €
21 249 000 €
18 061 000 €
13 973 000 €
20 399 000 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
222 005 000 €
219 265 000 €
230 520 000 €
190 992 000 €
178 351 000 €
162 648 000 €
168 336 000 €
148 997 000 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
333 106 000 €
351 845 000 €
308 110 000 €
379 496 000 €
224 117 000 €
210 753 000 €
216 289 000 €
238 052 000 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
1 683 947 000 €
1 612 123 000 €
1 565 772 000 €
1 426 111 000 €
1 049 831 000 €
949 980 000 €
952 481 000 €
979 392 000 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
90 473 000 €
88 840 000 €
75 910 000 €
169 971 000 €
46 521 000 €
38 629 000 €
41 601 000 €
39 631 000 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
217 749 000 €
208 796 000 €
241 024 000 €
251 789 000 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
781 123 000 €
684 757 000 €
696 182 000 €
699 250 000 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
74.40 %
72.08 %
73.09 %
71.40 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
576 311 000 €
619 821 000 €
638 667 000 €
632 015 000 €
267 904 000 €
264 351 000 €
254 335 000 €
277 858 000 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-
-6 549 000 €
37 835 000 €
68 920 000 €
Last revenue report of CompuGroup Medical Societas Europaea was 30/06/2021. According to last financial report total revenue in CompuGroup Medical Societas Europaea was 248 891 000 Euro and changed by +29.91% since last year. Net income in CompuGroup Medical Societas Europaea was 17 163 000 € in last quartal, net income changes to +22.83%.
Current cash CompuGroup Medical Societas Europaea - the sum of all of the cash a company has on the date of report. Current cash CompuGroup Medical Societas Europaea is 90 473 000 €
CompuGroup Medical Societas Europaea stocks data
COP.DE stock price
CompuGroup Medical Societas Europaea stock price today, COP.DE stock quote.
